Airfinity Ltd

Airfinity Ltd company information, Employees & Contact Information

Explore related pages

Related company profiles:

Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global life span. Specialising in infectious diseases, Airfinity works with the entire life science ecosystem. Our suite of proprietary surveillance tools and forecast models analyse and predict disease outcomes. Spanning over 150 viral, bacterial and fungal pathogens, we use advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. By combining this with expert analysis and commentary from our team of scientists, engineers and researchers, we are able to produce actionable insights to reduce health and economic burden.

Company Details

Employees
85
Founded
-
Address
71-75 Shelton Street, London,london Wc2h 9bp,united Kingdom
Industry
Information Services
NAICS
Other Information Services
News Syndicates
All Other Information Services
HQ
London, London
Looking for a particular Airfinity Ltd employee's phone or email?

Airfinity Ltd Questions

News

A strong pandemic defence system could reduce the chance of another COVID like pandemic in the next ten years from 27.5% to 8% - Airfinity

A strong pandemic defence system could reduce the chance of another COVID like pandemic in the next ten years from 27.5% to 8% Airfinity

The West should be on a war footing for the next pandemic - Airfinity

The West should be on a war footing for the next pandemic Airfinity

Airfinity’s COVID-19 forecast for China infections and deaths - Airfinity

Airfinity’s COVID-19 forecast for China infections and deaths Airfinity

Airfinity launches obesity intelligence solution to forecast and simulate obesity related outcomes - Airfinity

Airfinity launches obesity intelligence solution to forecast and simulate obesity related outcomes Airfinity

France could see local dengue cases rise 50-fold by 2030 as temperatures rise - Airfinity

France could see local dengue cases rise 50-fold by 2030 as temperatures rise Airfinity

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination - Airfinity

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination Airfinity

Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe - Airfinity

Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe Airfinity

Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people - Airfinity

Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people Airfinity

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity - Airfinity

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity Airfinity

Is the world prepared for a potential H5N1 bird flu pandemic? - Airfinity

Is the world prepared for a potential H5N1 bird flu pandemic? Airfinity

China’s COVID-19 wave forecast to have two peaks where cases could reach 4.2 million a day - Airfinity

China’s COVID-19 wave forecast to have two peaks where cases could reach 4.2 million a day Airfinity

Global wastage of COVID-19 vaccines could be 1.1 billion doses - Airfinity

Global wastage of COVID-19 vaccines could be 1.1 billion doses Airfinity

‘Tripledemic’ peak in US and UK hospitalisations to be smaller than last year as new COVID waves start in both countries - Airfinity

‘Tripledemic’ peak in US and UK hospitalisations to be smaller than last year as new COVID waves start in both countries Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases - Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases Airfinity

Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death - Airfinity

Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death Airfinity

COVID-19 vaccine market forecast to grow 29% to $84.9B in 2022, according to Airfinity - Airfinity

COVID-19 vaccine market forecast to grow 29% to $84.9B in 2022, according to Airfinity Airfinity

Reflecting on 2024: Conflict, climate and new pathogen strains shaped global disease trends - Airfinity

Reflecting on 2024: Conflict, climate and new pathogen strains shaped global disease trends Airfinity

China risks between 1.3 and 2.1 million deaths if it ends its zero-COVID strategy - Airfinity

China risks between 1.3 and 2.1 million deaths if it ends its zero-COVID strategy Airfinity

China’s second COVID-19 wave to be smaller than its first peaking at 11 million cases a week, predicts Airfinity - Airfinity

China’s second COVID-19 wave to be smaller than its first peaking at 11 million cases a week, predicts Airfinity Airfinity

Airfinity sponsors Team Ocean Warrior, the first ever Scandinavian boat to row across the Mid Pacific Ocean - Airfinity

Airfinity sponsors Team Ocean Warrior, the first ever Scandinavian boat to row across the Mid Pacific Ocean Airfinity

Airfinity launches new platform IDA to track all infectious disease vaccine and treatment candidates - Airfinity

Airfinity launches new platform IDA to track all infectious disease vaccine and treatment candidates Airfinity

Moderna more effective than Pfizer in direct comparison against the Delta variant - Airfinity

Moderna more effective than Pfizer in direct comparison against the Delta variant Airfinity

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir - Airfinity

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir Airfinity

GSK releases positive data on its RSV vaccine for older adults, RSV OA - Airfinity

GSK releases positive data on its RSV vaccine for older adults, RSV OA Airfinity

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers - Airfinity

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers Airfinity

COVID-19 vaccine makers raise prices to off set falling revenue as demand for jabs drops - Airfinity

COVID-19 vaccine makers raise prices to off set falling revenue as demand for jabs drops Airfinity

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market - Airfinity

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market Airfinity

300% rise in approved new cancer treatments in the last two decades, with US cancer moonshot goal achievable by 2048 - Airfinity

300% rise in approved new cancer treatments in the last two decades, with US cancer moonshot goal achievable by 2048 Airfinity

Comparing the burden of COVID-19 to seasonal flu: what does the data say? - Airfinity

Comparing the burden of COVID-19 to seasonal flu: what does the data say? Airfinity

Elderly RSV vaccines to generate $10.5B annually by 2030 in G7 countries - Airfinity

Elderly RSV vaccines to generate $10.5B annually by 2030 in G7 countries Airfinity

US FDA has extended the PDUFA target date for Legend Biotech/Janssen’s Cilta-Cel from November 29, 2021, to February 28, 2022. - Airfinity

US FDA has extended the PDUFA target date for Legend Biotech/Janssen’s Cilta-Cel from November 29, 2021, to February 28, 2022. Airfinity

Oncopeptides withdraws its peptide-drug conjugate (PCD) Pepaxto from the US market - Airfinity

Oncopeptides withdraws its peptide-drug conjugate (PCD) Pepaxto from the US market Airfinity

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue - Airfinity

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue Airfinity

A Machine Learning-enabled SIR Model for Adaptive and Dynamic Forecasting of COVID-19 - medRxiv

A Machine Learning-enabled SIR Model for Adaptive and Dynamic Forecasting of COVID-19 medRxiv

Value of investment on NCDs: Impact on health outcomes in low- and middle-income countries - IFPMA

Value of investment on NCDs: Impact on health outcomes in low- and middle-income countries IFPMA

Airfinity gives decision makers big picture on health - Financial Times

Airfinity gives decision makers big picture on health Financial Times

China COVID deaths accelerate to 9,000 a day - UK research firm Airfinity - Reuters

China COVID deaths accelerate to 9,000 a day - UK research firm Airfinity Reuters

With new CDC recommendations, RSV market's long-term value falls sharply in US: Airfinity - Fierce Pharma

With new CDC recommendations, RSV market's long-term value falls sharply in US: Airfinity Fierce Pharma

Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels - GlobeNewswire

Global surge in infectious diseases as over 40 countries report outbreaks 10-fold over pre-pandemic levels GlobeNewswire

China COVID deaths probably running above 5,000 per day - UK research firm Airfinity - Reuters

China COVID deaths probably running above 5,000 per day - UK research firm Airfinity Reuters

Disease forecasters predict a 27% chance of another COVID-like pandemic within 10 years | Fortune Well - Fortune

Disease forecasters predict a 27% chance of another COVID-like pandemic within 10 years | Fortune Well Fortune

How a little-known London start-up predicted China’s deadly Covid outbreak - The Telegraph

How a little-known London start-up predicted China’s deadly Covid outbreak The Telegraph

Pfizer's Covid Pill Is Poised to Be Among the Fastest-Selling Treatments of All Time - Bloomberg

Pfizer's Covid Pill Is Poised to Be Among the Fastest-Selling Treatments of All Time Bloomberg

Trane adds VFD options to Airfinity rooftops - Cooling Post

Trane adds VFD options to Airfinity rooftops Cooling Post

Yes, Everyone Really Is Sick a Lot More Often After Covid - Bloomberg

Yes, Everyone Really Is Sick a Lot More Often After Covid Bloomberg

Beldray Airfinity Cordless Vacuum Cleaner review: this cable-free cleaner packs a punch - T3

Beldray Airfinity Cordless Vacuum Cleaner review: this cable-free cleaner packs a punch T3

'I tested a cheaper vacuum cleaner on years of hair build-up - the results were wild' - The Mirror

'I tested a cheaper vacuum cleaner on years of hair build-up - the results were wild' The Mirror

Top Airfinity Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant